血清可溶性PD-1水平与2型糖尿病患者并发颈动脉粥样硬化斑块的关系

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (571 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the relationship between serum soluble PD-1 (sPD-1) level and carotid atherosclerotic plaque in type 2 diabetes mellitus （T2DM） patients. Methods From October 2016 to March 2019，100 cases with T2DM patients who admitted to the First People′s Hospital of Nanning of Guangxi Zhuang Autonomous Region were selected. According to the presence or absence of carotid atherosclerotic plaque, they were divided into plaque group (54 cases) and non-plaque group (46 cases). General information, biochemical index and the serum sPD-1 level and carotid Crouse integral of two groups were compared. Logistic regression analysis was used for multivariate analysis. Results The systolic blood pressure level and the proportion of smoking and drinking in plaque group were higher than those in non-plaque group (P < 0.05). The C-reactive protein, triacylglycerol levels in plaque group were higher than those in non-plaque group (P < 0.05). Serum sPD-1 levels and carotid Crouse integral in plaque group were higher than those in non-plaque group (P < 0.05), and serum sPD-1 level was positively correlated with carotid Crouse integral (r = 0.384, P = 0.023). Logistic regression analysis showed that smoking, drinking, C-reactive protein and sPD-1 level were independent risk factors for carotid atherosclerotic plaque formation in T2DM patients (P < 0.05). ROC curve analysis showed that the critical value of sPD-1 was 1.41 ng/mL, the area under the curve was 0.824, the sensitivity was 81.24%, the specificity was 78.79% (95%CI:0.669-0.979，P = 0.027). Conclusion Serum sPD-1 level may all increase the risk of carotid atherosclerotic plaque formation in T2DM patients. Monitoring serum sPD-1 level can be used to diagnose carotid atherosclerotic plaque.

Key words： Type 2 diabetes mellitus Carotid atherosclerotic plaque Soluble PD-1 Carotid Crouse integral

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIN Yuanyuan ZOU Xinyu HUANG Xuemei WEI Haitao

Cite this article:

LIN Yuanyuan ZOU Xinyu HUANG Xuemei WEI Haitao. Relationship between serum soluble PD-1 level and carotid atherosclerotic plaque in type 2 diabetes mellitus patients[J]. 中国医药导报, 2020, 17(11): 53-56.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2020/V17/I11/53

[1] 刘国荣，高素玲，张江，等.老年高血压缺血性脑卒中合并2型糖尿病患者颈动脉粥样硬化程度的分析[J].中华老年心脑血管病杂志，2013，15（6）：607-610.
[2] 季翔，张霞.超声心动图评价2型糖尿病患者心脏功能的研究进展[J].临床超声医学杂志，2019，21（10）：772-775.
[3] 汤广锋，徐雯，李昉，等.2型糖尿病患者颈动脉粥样硬化斑块形成的危险因素分析[J].安徽医学，2014，23（11）：1506-1508.
[4] Wang Y，Pang N，Wang X，et al. Percentages of PD-1+CD4+T cells and PD-L1+DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia [J]. Hum Vaccin Immunother，2018，14（4）：832-838.
[5] Kruger S，Legenstein ML，R?觟sgen V，et al. Serum levels of soluble programmed death protein 1（sPD-1）and soluble programmed death ligand 1（sPD-L1）in advanced pancreatic cancer [J]. Oncoimmunology，2017，6（5）：e1310358.
[6] 中华医学会糖尿病学分会.中国糖尿病防治指南（2017年版）[J].中华糖尿病杂志，2018，10（1）：4-67.
[7] 韩超，周梦，杨嘉琦，等.绝经激素治疗对绝经早期女性颈动脉内膜中层厚度的影响[J].中西医结合心脑血管病杂志，2019，17（14）：2160-2161.
[8] 刘昌盛，司庆盈，王霞，等.2型糖尿病合并急性脑梗死患者血清sCD40L与颈动脉粥样硬化的相关性[J].山东大学学报：医学版，2010，48（3）：27-29.
[9] 周立平，于志坚.联合检测糖代谢及胰岛功能各指标在新诊断2型糖尿病患者诊疗中的价值分析[J].中国医药科学，2018，8（11）：133-135，139.
[10] 袁雪红，黄晓新，贾颐，等.颈动脉粥样硬化斑块的超声组织特征对2型糖尿病患者心脑血管事件预测的意义[J].国际脑血管病杂志，2018，26（7）：533-537.
[11] 黄娜娜，陈述林.2型糖尿病患者不同部位斑块发生情况及影响因素分析[J].中国医药导报，2017，14（24）：81-84.
[12] 曲歌乐，钱玉英，周英智，等.2型糖尿病患者血清同型半胱氨酸与凝血指标致动脉粥样硬化的作用[J].山西医科大学学报，2017，48（1）：34-39.
[13] 杨平，廖萍，伍文娟，等.血清同型半胱氨酸、C反应蛋白与2型糖尿病伴脑梗死患者颈动脉粥样硬化的关系[J].中国医药导报，2019，16（5）：126-129，141.
[14] 谭安隽，李天荣，李红，等.老年2型糖尿病、糖耐量减低患者CRP、TNF－α与颈动脉粥样硬化及胰岛素抵抗的相关性[J].中国老年学杂志，2015，24（14）：3878-3880.
[15] 王彩琴，应鸣翘，薛群，等.可诱导共刺激分子与程序性死亡-1在重症肌无力患者外周血表达的研究[J].中华神经科杂志，2018，51（2）：105-110.
[16] 李媛媛，李天艺，焦文君，等.老年2型糖尿病患者骨钙素水平与颈动脉粥样硬化的相关性研究[J].中国糖尿病杂志，2015，23（10）：885-887.
[17] Bian B，Fanale D，Dusetti N，et al. Prognostic significance of circulating PD-1，PD-L1，pan-BTN3As，BTN3A1 and BTLA in patients with pancreatic adenocarcinoma [J]. Oncoimmunology，2019，8（4）：e1561120.
[18] 孙钧，郑继伟，贾凡，等.2型糖尿病患者血清IL-10水平与颈动脉粥样硬化的关系[J].国际检验医学杂志，2018，39（5）：538-551.
[19] 刘晓洁，梅涛，麻红艳，等.单纯2型糖尿病患者颈动脉粥样硬化斑块形成及其稳定性影响因素分析[J].吉林大学学报：医学版，2018，44（2）：350-355.
[20] 于婷婷，黄娜娜，苏娇，等.2型糖尿病患者颈动脉粥样硬化斑块与骨密度的相关性分析[J].中国动脉硬化杂志，2019，27（1）：45-50.
[21] Chen，付苏.PD-L1通过PD-1受体抑制伤害性感受神经元活动并减轻急慢性疼痛[J].中国疼痛医学杂志，2017， 23（7）：506.
[22] 陈栖栖，田娟，张晶，等.类风湿关节炎患者血清IL-37和可溶性PD-1分子的表达水平及临床意义[J].中国免疫学杂志，2017，33（3）：422-425.